Tianda Pharmaceuticals Ltd
HKEX:455
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tianda Pharmaceuticals Ltd
Revenue
Tianda Pharmaceuticals Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tianda Pharmaceuticals Ltd
HKEX:455
|
Revenue
HK$322.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Revenue
HK$12.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Revenue
¥31.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Revenue
HK$269.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Revenue
$548.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
12%
|
|
Tianda Pharmaceuticals Ltd
Glance View
Tianda Pharmaceuticals Ltd. operates as an investment holding company, which engages in the research and development, manufacture and sale of pharmaceutical, biotechnology and healthcare products. The company employs 714 full-time employees The main businesses of the Company include the research and development, production and sales of pharmaceutical, biotechnology and healthcare products. Its products include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. The firm operates businesses in Hong Kong, China and Australia.
See Also
What is Tianda Pharmaceuticals Ltd's Revenue?
Revenue
322.9m
HKD
Based on the financial report for Dec 31, 2025, Tianda Pharmaceuticals Ltd's Revenue amounts to 322.9m HKD.
What is Tianda Pharmaceuticals Ltd's Revenue growth rate?
Revenue CAGR 3Y
-8%
Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Tianda Pharmaceuticals Ltd have been -8% over the past three years .
